Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › BTLA fusion protein agonists and uses thereof

BTLA fusion protein agonists and uses thereof

US Patent 10961297 · Granted Mar 30, 2021

Estimated economic value: $1,245,678,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lymphocyte function-associated antigen 3 (LFA3) variant polypeptides and methods2024
BTLA fusion protein agonists and uses thereof2024
BTLA fusion protein agonists and uses thereof2024
BTLA fusion protein agonists and uses thereof2024
BTLA fusion protein agonists and uses thereof2024
BTLA fusion protein agonists and uses thereof2024
Anti-IL-2 antibodies and compositions and uses thereof2022
Compositions and methods for treating autoimmune and inflammatory disorders2022
Compositions and methods for treating autoimmune and inflammatory disorders2022
Modulation of immune response using BTLA agonist antibodies2022
Modulation of immune response using BTLA agonist antibodies2022
Modulation of γδ T cells2020